Why the study?
Despite advances in understanding the atrial substrate, management of atrial arrhythmias in hypertrophic cardiomyopathy remains challenging due to safety concerns with pharmacological therapies and lower efficacy of catheter ablation.
This review highlights the complex atrial remodeling in hypertrophic cardiomyopathy and the ongoing challenges in managing associated atrial arrhythmias, emphasizing the need for improved interventional strategies.
Hypertrophic cardiomyopathy is the most common inherited cardiac condition, associated with increased risks of heart failure, arrhythmias, and sudden cardiac death. Once considered a disease of the ventricular myocardium, growing evidence points towards atrial involvement, with structural and electrical atrial remodelling driven by a complex interplay of genetic, electrophysiological and hemodynamic factors. Despite advances in the understanding of this atrial substrate, management of atrial arrhythmias in hypertrophic cardiomyopathy remains challenging. Pharmacological therapies are limited by safety concerns, and catheter ablation shows lower efficacy in patients with hypertrophic cardiomyopathy compared to patients with structurally normal hearts. This review synthesizes current knowledge of disease related changes underlying atrial arrhythmias in hypertrophic cardiomyopathy and outlines diagnostic and therapeutic strategies. Particular emphasis is given to interventional treatment approaches, including emerging technologies and their evolving role in patients with hypertrophic cardiomyopathy.
No takes yet. Share an insight, caveat, or question.
Klis et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: